Page 79 - Screening for Cervical Cancer: Systematic Evidence Review

References

devices: a systematic review and meta-analysis [published erratum appears in
Lancet 2000 Jan 29;355(9201):414]. Lancet. 1999;354:1763-1770.

28. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the
second National Cancer Institute Workshop, April 29-30, 1991. Acta Cytologica.
1993;37(2):115-124.

29. Richart RM. Cervical intraepithelial neoplasia. Pathol Annu. 1973;8:301-328.

30. Reagan JW, Fu YS. Histologic types and prognosis of cancers of the uterine cervix. Int J
Radiat Oncol Biol Phys. 1979;5:1015-1020.

31. Nyirjesy I. Atypical or suspicious cervical smears. An aggressive diagnostic approach. J
Am Med Assoc. 1972;222:691-693.

32. McCrory DC, Mather DB, Bastian L. Evaluation of Cervical Cytology: Evidence Report
Number 5, SummaryAgency for Health Care Policy and Research. Rockville,
MD: Agency for Health Care Policy and Research; 1999.

33. Harris RP, Helfand M, Woolf SH, et al. Current Methods of the US Preventive Services
Task Force: A Review of the Process. Am J Prev Med. 2001;2 (3S):21-35.

34. Kainz C, Gitsch G, Heinzl H, Breitenecker G. Incidence of cervical smears indicating
dysplasia among Austrian women during the 1980s. Br J Obstet Gynaecol.
1995;102:541-544.

35. Gram IT, Macaluso M, Stalsberg H. Incidence of cervical intraepithelial neoplasia grade
III, and cancer of the cervix uteri following a negative Pap-smear in an
opportunistic screening. Acta Obstet Gynecol Scand. 1998;77:228-232.

36. Sawaya GF, Kerlikowske K, Lee NC. When can cervical cancer screening intervals be
lengthened? Outcomes following 1, 2, and 3 or more normal cervical smears.
(unpublished data).

37. Forsmo S, Jacobsen BK, Stalsberg H. Cervical neoplasia in pap smears: risk of cervical
intra-epithelial neoplasia (CIN) after negative or no prior smears in a population
without a mass screening programme. Int J Epidemiol. 1996;25:53-58.

38. Gustafsson L, Sparen P, Gustafsson M, et al. Low efficiency of cytologic screening for
cancer in situ of the cervix in older women. Int J Cancer. 1995;63:804-809.

39. Cruickshank ME, Angus V, Kelly M, McPhee S, Kitchener HC. The case for stopping
cervical screening at age 50. Brit J Obstet Gynaecol. 1997;104:586-589.

40. Lawson HW, Lee NC, Thames SF, Henson R, Miller DS. Cervical cancer screening
among low-income women: results of a national screening program, 1991-1995.
Obstet Gynecol. 1998;92:745-752.

85